Healthcare Services Group (HCSG) Financials

$9.65 -0.14 (-1.43%)

Closing price 04:00 PM Eastern

Extended Trading

$9.65 0.00 (0.00%)

As of 06:23 PM Eastern

Annual Income Statements for Healthcare Services Group

This table shows Healthcare Services Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	88	84	65	99	47	27	40	39
Consolidated Net Income / (Loss)	88	84	65	99	49	34	38	39
Net Income / (Loss) Continuing Operations	88	84	65	99	49	34	38	39
Total Pre-Tax Income	133	100	85	129	66	45	53	53
Total Operating Income	124	98	78	117	57	53	48	45
Total Gross Profit	251	234	228	268	231	193	215	228
Total Revenue	1,861	2,003	1,841	1,760	1,642	1,690	1,671	1,716
Operating Revenue	1,861	2,003	1,841	1,760	1,642	1,690	1,671	1,716
Total Cost of Revenue	1,611	1,768	1,613	1,492	1,411	1,497	1,457	1,488
Operating Cost of Revenue	1,611	1,768	1,613	1,492	1,411	1,497	1,457	1,488
Total Operating Expenses	127	137	150	151	173	140	167	183
Selling, General & Admin Expense	127	137	150	151	173	140	167	183
Total Other Income / (Expense), net	9.08	2.07	7.22	12	8.05	-8.41	5.08	7.91
Interest & Investment Income	10	2.07	7.22	12	8.05	-8.41	5.08	7.91
Income Tax Expense	45	16	21	31	17	10	15	13
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	1.56	7.48	-1.63	0.47
Basic Earnings per Share	$1.20	$1.13	$0.87	$1.32	$0.65	$0.46	$0.52	$0.54
Weighted Average Basic Shares Outstanding	73.36M	74.00M	74.36M	74.70M	74.82M	74.34M	74.29M	73.75M
Diluted Earnings per Share	$1.19	$1.12	$0.87	$1.32	$0.65	$0.46	$0.52	$0.53
Weighted Average Diluted Shares Outstanding	74.35M	74.61M	74.59M	74.79M	74.96M	74.35M	74.34M	73.99M
Weighted Average Basic & Diluted Shares Outstanding	73.50M	73.90M	74.40M	74.72M	74.00M	74.39M	73.58M	73.49M

This table shows Healthcare Services Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-1.97	11	13	7.39	-6.69	26	15	-2.23	16	10
Consolidated Net Income / (Loss)	0.32	16	12	8.25	-5.05	24	15	-1.79	14	12
Net Income / (Loss) Continuing Operations	0.32	16	12	8.25	-5.05	24	15	-1.79	14	12
Total Pre-Tax Income	0.99	20	16	11	-6.33	32	21	-1.99	19	15
Total Operating Income	1.79	17	15	9.30	-4.60	28	18	-2.89	17	14
Total Gross Profit	38	57	55	51	34	75	65	42	63	59
Total Revenue	414	424	417	419	411	424	423	426	428	438
Operating Revenue	414	424	417	419	411	424	423	426	428	438
Total Cost of Revenue	377	367	362	368	377	349	359	385	365	379
Operating Cost of Revenue	377	367	362	368	377	349	359	385	365	379
Total Operating Expenses	36	40	40	41	39	46	47	44	47	45
Selling, General & Admin Expense	36	40	40	41	39	46	47	44	47	45
Total Other Income / (Expense), net	-0.80	2.37	1.35	1.64	-1.74	3.83	3.70	0.91	2.28	1.03
Interest & Investment Income	-0.80	2.37	1.35	1.64	-1.74	3.83	3.70	0.91	2.28	1.03
Income Tax Expense	0.67	3.76	4.48	2.68	-1.29	8.79	6.01	-0.20	4.78	2.89
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	2.29	-	-1.21	0.86	1.65	-2.93	0.33	0.45	-2.09	1.79
Basic Earnings per Share	$0.00	$0.22	$0.16	$0.11	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.16
Weighted Average Basic Shares Outstanding	74.34M	74.34M	74.50M	74.48M	74.36M	74.29M	73.93M	73.85M	73.69M	73.75M
Diluted Earnings per Share	$0.00	$0.22	$0.16	$0.11	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.15
Weighted Average Diluted Shares Outstanding	74.35M	74.35M	74.52M	74.57M	74.36M	74.34M	74.06M	73.85M	73.93M	73.99M
Weighted Average Basic & Diluted Shares Outstanding	74.09M	74.39M	74.20M	74.20M	73.85M	73.58M	73.65M	73.38M	73.29M	73.49M

This table details how cash moves in and out of Healthcare Services Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-14	16	1.30	112	-69	-45	28	5.80
Net Cash From Operating Activities	7.63	80	94	217	37	-8.17	43	31
Net Cash From Continuing Operating Activities	7.63	80	94	217	37	-8.17	43	31
Net Income / (Loss) Continuing Operations	88	84	65	99	49	34	38	39
Consolidated Net Income / (Loss)	88	84	65	99	49	34	38	39
Depreciation Expense	8.89	9.27	14	14	15	15	14	15
Amortization Expense	1.30	1.37	1.43	1.82	2.28	2.22	2.14	1.50
Non-Cash Adjustments To Reconcile Net Income	12	59	25	9.45	14	52	39	49
Changes in Operating Assets and Liabilities, net	-103	-73	-11	93	-43	-112	-50	-74
Net Cash From Investing Activities	-15	-9.59	-16	-37	-23	2.58	-3.29	6.05
Net Cash From Continuing Investing Activities	-15	-9.59	-16	-37	-23	2.58	-3.29	6.05
Purchase of Property, Plant & Equipment	-5.40	-4.94	-4.37	-4.34	-5.69	-5.21	-5.41	-6.34
Acquisitions	-4.58	-	0.00	0.00	-24	-0.11	0.00	-2.75
Purchase of Investments	-34	-14	-34	-39	-20	-2.88	0.00	-52
Sale of Property, Plant & Equipment	0.34	0.64	0.20	0.27	0.21	0.39	0.12	0.21
Sale and/or Maturity of Investments	29	9.01	21	6.27	27	10	1.99	67
Net Cash From Financing Activities	-6.96	-54	-76	-68	-83	-39	-12	-31
Net Cash From Continuing Financing Activities	-6.96	-54	-76	-68	-83	-39	-12	-31
Repayment of Debt	-	-5.38	-20	-10	0.00	25	0.00	-25
Repurchase of Common Equity	-	-0.28	-0.59	-0.68	-23	-1.07	-12	-6.05
Payment of Dividends	-55	-57	-59	-61	-62	-63	0.00	0.00
Issuance of Common Equity	0.10	0.09	0.09	0.09	0.09	0.11	0.00	0.00
Other Financing Activities, net	13	8.80	3.63	2.92	2.43	0.41	0.00	0.00
Cash Interest Paid	1.36	3.09	3.46	1.37	1.39	2.82	7.81	6.49
Cash Income Taxes Paid	35	38	20	45	21	3.31	5.59	15

This table details how cash moves in and out of Healthcare Services Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-12	6.65	-10	13	2.65	23	-0.35	-24	-1.41	32
Net Cash From Operating Activities	-9.90	23	-16	7.40	2.94	49	-26	16	4.31	36
Net Cash From Continuing Operating Activities	-9.90	23	-16	7.40	2.94	49	-26	16	4.31	36
Net Income / (Loss) Continuing Operations	0.32	16	12	8.25	-5.05	24	15	-1.79	14	12
Consolidated Net Income / (Loss)	0.32	16	12	8.25	-5.05	24	15	-1.79	14	12
Depreciation Expense	3.80	3.76	3.72	3.60	3.25	3.78	3.53	3.68	3.77	3.60
Amortization Expense	0.55	0.55	0.53	0.54	0.54	0.54	0.46	0.34	0.21	0.50
Non-Cash Adjustments To Reconcile Net Income	9.91	8.86	7.59	12	18	1.70	3.48	33	0.31	12
Changes in Operating Assets and Liabilities, net	-24	-6.04	-40	-17	-14	20	-49	-19	-14	7.81
Net Cash From Investing Activities	-1.29	-0.29	-0.74	0.11	-1.27	-1.38	12	-28	0.29	22
Net Cash From Continuing Investing Activities	-1.29	-0.29	-0.74	0.11	-1.27	-1.38	12	-28	0.29	22
Purchase of Property, Plant & Equipment	-1.56	-1.07	-1.01	-1.09	-1.88	-1.43	-2.20	-1.31	-1.40	-1.43
Purchase of Investments	-	-	-	-	-	-	-	-	-14	-0.60
Sale of Property, Plant & Equipment	-0.01	0.21	0.06	0.03	0.04	-	0.03	0.13	0.04	0.02
Sale and/or Maturity of Investments	0.29	0.57	0.21	1.17	0.57	0.05	17	11	15	24
Net Cash From Financing Activities	-0.87	-16	6.91	5.00	0.98	-25	14	-13	-6.01	-26
Net Cash From Continuing Financing Activities	-0.87	-16	6.91	5.00	0.98	-25	14	-13	-6.01	-26
Repurchase of Common Equity	-0.00	-	-3.09	-	-4.02	-5.05	-1.03	-3.00	-1.01	-1.01

This table presents Healthcare Services Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	676	693	723	785	778	721	791	803
Total Current Assets	527	508	516	572	546	509	572	557
Cash & Equivalents	9.56	26	27	139	71	26	54	57
Restricted Cash	-	-	-	-	-	-	0.00	28
Short-Term Investments	73	76	91	125	114	95	93	51
Note & Lease Receivable	379	342	341	255	293	337	39	51
Accounts Receivable	-	-	-	-	-	-	345	331
Inventories, net	42	41	37	32	26	21	18	17
Prepaid Expenses	24	22	20	21	33	23	22	22
Plant, Property, & Equipment, net	14	13	0.00	0.00	28	23	29	28
Total Noncurrent Assets	135	172	207	213	203	189	190	218
Noncurrent Note & Lease Receivables	15	43	47	34	29	33	25	41
Goodwill	51	51	51	51	75	76	76	76
Intangible Assets	31	27	22	18	21	16	12	9.44
Noncurrent Deferred & Refundable Income Taxes	7.50	21	20	36	32	31	35	38
Employee Benefit Assets	29	29	37	47	47	33	41	50
Other Noncurrent Operating Assets	1.26	1.26	29	27	0.00	0.81	1.66	4.09
Total Liabilities & Shareholders' Equity	676	693	723	785	778	721	791	803
Total Liabilities	276	252	262	305	325	303	334	303
Total Current Liabilities	184	163	149	162	191	189	217	193
Short-Term Debt	-	-	-	-	0.00	25	25	0.00
Accounts Payable	74	61	54	52	64	68	83	81
Accrued Expenses	4.56	8.89	16	18	27	18	21	25
Current Deferred & Payable Income Tax Liabilities	15	7.14	8.08	-	-	0.00	7.20	8.39
Current Employee Benefit Liabilities	54	35	36	71	76	55	58	53
Other Current Liabilities	35	51	33	22	24	23	23	25
Total Noncurrent Liabilities	92	88	114	142	134	114	117	110
Capital Lease Obligations	-	-	-	11	11	8.10	11	8.03
Noncurrent Employee Benefit Liabilities	92	30	102	131	112	99	103	102
Other Noncurrent Operating Liabilities	-	-	12	0.00	10	6.14	2.99	0.39
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	400	441	460	480	453	418	457	500
Total Preferred & Common Equity	400	441	460	480	453	418	457	500
Total Common Equity	400	441	460	480	453	418	457	500
Common Stock	245	260	271	283	295	303	311	319
Retained Earnings	164	190	195	201	184	147	185	225
Treasury Stock	-9.86	-9.66	-9.44	-8.96	-30	-28	-38	-41
Accumulated Other Comprehensive Income / (Loss)	0.84	0.16	2.92	5.56	4.00	-3.48	-1.84	-2.32

This table presents Healthcare Services Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	722	719	762	751	804	800	806
Total Current Assets	513	510	549	533	580	573	578
Cash & Equivalents	20	16	29	31	29	26	27
Restricted Cash	-	-	-	-	25	25	26
Short-Term Investments	94	96	93	90	76	79	77
Note & Lease Receivable	347	351	380	368	407	399	406
Inventories, net	23	20	20	19	18	18	17
Prepaid Expenses	24	25	26	24	26	26	25
Plant, Property, & Equipment, net	24	23	27	29	29	30	28
Total Noncurrent Assets	185	186	186	188	194	197	199
Noncurrent Note & Lease Receivables	27	32	31	29	23	21	23
Goodwill	76	76	76	76	76	76	76
Intangible Assets	17	15	14	13	11	11	10
Noncurrent Deferred & Refundable Income Taxes	34	28	28	33	35	39	36
Employee Benefit Assets	32	34	37	36	44	46	49
Other Noncurrent Operating Assets	-	0.76	0.71	1.81	4.30	4.51	5.61
Total Liabilities & Shareholders' Equity	722	719	762	751	804	800	806
Total Liabilities	300	279	311	309	329	328	317
Total Current Liabilities	182	162	190	188	209	209	197
Short-Term Debt	25	35	40	45	40	30	25
Accounts Payable	67	64	66	71	73	72	77
Accrued Expenses	16	17	17	20	22	23	26
Current Deferred & Payable Income Tax Liabilities	-	-	1.36	1.27	12	4.28	4.50
Current Employee Benefit Liabilities	47	22	41	26	40	58	44
Other Current Liabilities	26	24	25	25	23	22	22
Total Noncurrent Liabilities	118	116	122	121	120	119	120
Capital Lease Obligations	8.75	8.59	12	12	11	11	9.03
Noncurrent Employee Benefit Liabilities	102	101	106	106	107	107	110
Other Noncurrent Operating Liabilities	8.00	6.45	3.85	3.12	2.27	0.72	0.43
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	422	441	451	442	475	471	489
Total Preferred & Common Equity	422	441	451	442	475	471	489
Total Common Equity	422	441	451	442	475	471	489
Common Stock	301	304	307	309	313	315	317
Retained Earnings	155	167	176	170	200	199	213
Treasury Stock	-28	-29	-29	-33	-36	-39	-40
Accumulated Other Comprehensive Income / (Loss)	-5.51	-2.27	-3.13	-4.78	-2.17	-2.62	-0.52

This table displays calculated financial ratios and metrics derived from Healthcare Services Group's official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	19.10%	7.60%	-8.08%	-4.37%	-6.72%	2.94%	-1.11%	2.65%
EBITDA Growth	5.59%	-19.08%	-14.04%	42.94%	-44.19%	-5.24%	-8.57%	-5.19%
EBIT Growth	5.21%	-21.03%	-20.40%	50.50%	-50.98%	-7.82%	-9.43%	-6.14%
NOPAT Growth	8.58%	-0.50%	-27.74%	51.48%	-52.45%	-4.38%	-14.74%	-3.27%
Net Income Growth	13.99%	-5.33%	-22.68%	52.80%	-50.81%	-29.46%	12.10%	2.83%
EPS Growth	13.33%	-5.88%	-22.32%	51.72%	-50.76%	-29.23%	13.04%	1.92%
Operating Cash Flow Growth	-81.57%	948.90%	16.93%	132.11%	-82.92%	-122.01%	632.61%	-29.19%
Free Cash Flow Firm Growth	-44.70%	393.03%	-8.81%	269.92%	-104.27%	-19.16%	284.75%	-64.75%
Invested Capital Growth	28.28%	6.69%	1.14%	-33.54%	22.55%	18.33%	4.70%	7.76%
Revenue Q/Q Growth	5.43%	0.02%	-2.54%	-1.33%	-0.17%	0.21%	-0.01%	0.82%
EBITDA Q/Q Growth	0.04%	8.16%	-12.93%	4.37%	-25.96%	26.12%	21.31%	-19.60%
EBIT Q/Q Growth	-0.26%	9.49%	-16.32%	5.03%	-31.48%	37.84%	30.85%	-24.60%
NOPAT Q/Q Growth	-3.50%	26.31%	-22.52%	7.35%	-32.55%	38.49%	24.43%	-22.45%
Net Income Q/Q Growth	-0.13%	15.75%	-16.39%	9.85%	-32.11%	47.24%	25.24%	-22.70%
EPS Q/Q Growth	1.71%	14.29%	-15.53%	9.09%	-32.29%	53.33%	23.81%	-24.29%
Operating Cash Flow Q/Q Growth	15.19%	1.28%	9.14%	40.22%	-54.41%	-2,676.34%	156.69%	-30.06%
Free Cash Flow Firm Q/Q Growth	442.35%	37.23%	-6.88%	29.62%	-114.43%	72.63%	385.83%	-75.43%
Invested Capital Q/Q Growth	2.62%	2.64%	-1.27%	-16.50%	1.36%	-3.66%	-8.40%	-5.24%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	13.47%	11.71%	12.38%	15.22%	14.04%	11.44%	12.85%	13.29%
EBITDA Margin	7.20%	5.42%	5.07%	7.57%	4.53%	4.17%	3.86%	3.56%
Operating Margin	6.66%	4.89%	4.23%	6.66%	3.50%	3.13%	2.87%	2.62%
EBIT Margin	6.66%	4.89%	4.23%	6.66%	3.50%	3.13%	2.87%	2.62%
Profit (Net Income) Margin	4.74%	4.17%	3.51%	5.61%	2.96%	2.03%	2.30%	2.30%
Tax Burden Percent	66.35%	83.60%	75.89%	76.39%	74.10%	76.86%	72.35%	74.56%
Interest Burden Percent	107.33%	102.12%	109.27%	110.22%	114.02%	84.11%	110.59%	117.57%
Effective Tax Rate	33.65%	16.40%	24.11%	23.61%	25.90%	23.14%	27.65%	25.44%
Return on Invested Capital (ROIC)	29.13%	24.95%	17.37%	31.43%	16.82%	13.38%	10.28%	9.36%
ROIC Less NNEP Spread (ROIC-NNEP)	22.22%	23.08%	12.40%	26.50%	14.02%	18.31%	6.60%	4.42%
Return on Net Nonoperating Assets (RNNOA)	-5.24%	-5.08%	-3.03%	-10.45%	-6.42%	-5.51%	-1.50%	-1.10%
Return on Equity (ROE)	23.88%	19.87%	14.33%	20.98%	10.40%	7.86%	8.78%	8.25%
Cash Return on Invested Capital (CROIC)	4.35%	18.48%	16.23%	71.72%	-3.45%	-3.42%	5.69%	1.89%
Operating Return on Assets (OROA)	20.57%	14.30%	11.01%	15.55%	7.35%	7.07%	6.35%	5.65%
Return on Assets (ROA)	14.65%	12.21%	9.13%	13.09%	6.21%	4.57%	5.08%	4.95%
Return on Common Equity (ROCE)	23.88%	19.87%	14.33%	20.98%	10.40%	7.86%	8.78%	8.25%
Return on Equity Simple (ROE_SIMPLE)	22.06%	18.95%	14.03%	20.54%	10.72%	8.19%	8.41%	7.90%
Net Operating Profit after Tax (NOPAT)	82	82	59	90	43	41	35	34
NOPAT Margin	4.42%	4.08%	3.21%	5.09%	2.59%	2.41%	2.08%	1.96%
Net Nonoperating Expense Percent (NNEP)	6.91%	1.87%	4.97%	4.93%	2.80%	-4.93%	3.68%	4.94%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	9.02%	7.04%	6.61%
Cost of Revenue to Revenue	86.53%	88.29%	87.62%	84.78%	85.96%	88.56%	87.15%	86.71%
SG&A Expenses to Revenue	6.81%	6.82%	8.15%	8.57%	10.54%	8.30%	9.98%	10.67%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	6.81%	6.82%	8.15%	8.57%	10.54%	8.30%	9.98%	10.67%
Earnings before Interest and Taxes (EBIT)	124	98	78	117	57	53	48	45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	134	108	93	133	74	71	64	61
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.16	5.78	3.46	3.98	2.77	2.13	1.68	1.70
Price to Tangible Book Value (P/TBV)	10.26	7.02	4.12	4.65	3.51	2.72	2.08	2.05
Price to Revenue (P/Rev)	1.75	1.27	0.87	1.09	0.76	0.53	0.46	0.50
Price to Earnings (P/E)	36.97	30.53	24.68	19.39	26.69	33.22	19.14	21.83
Dividend Yield	1.69%	2.24%	3.69%	3.16%	4.95%	7.11%	0.00%	0.00%
Earnings Yield	2.70%	3.28%	4.05%	5.16%	3.75%	3.01%	5.23%	4.58%
Enterprise Value to Invested Capital (EV/IC)	10.02	7.23	4.31	7.30	3.87	2.43	1.90	1.94
Enterprise Value to Revenue (EV/Rev)	1.71	1.22	0.80	0.94	0.66	0.47	0.39	0.42
Enterprise Value to EBITDA (EV/EBITDA)	23.72	22.56	15.83	12.45	14.51	11.36	10.15	11.84
Enterprise Value to EBIT (EV/EBIT)	25.66	25.02	18.95	14.16	18.79	15.12	13.64	16.07
Enterprise Value to NOPAT (EV/NOPAT)	38.68	29.92	24.97	18.54	25.36	19.67	18.86	21.55
Enterprise Value to Operating Cash Flow (EV/OCF)	416.70	30.58	15.77	7.64	29.10	0.00	15.05	23.49
Enterprise Value to Free Cash Flow (EV/FCFF)	258.79	40.41	26.72	8.12	0.00	0.00	34.06	106.81
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.02	0.03	0.08	0.08	0.02
Long-Term Debt to Equity	0.00	0.00	0.00	0.02	0.03	0.02	0.02	0.02
Financial Leverage	-0.24	-0.22	-0.24	-0.39	-0.46	-0.30	-0.23	-0.25
Leverage Ratio	1.63	1.63	1.57	1.60	1.67	1.72	1.73	1.67
Compound Leverage Factor	1.75	1.66	1.72	1.77	1.91	1.45	1.91	1.96
Debt to Total Capital	0.00%	0.00%	0.00%	2.31%	2.44%	7.33%	7.35%	1.58%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	5.54%	5.07%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	2.31%	2.44%	1.79%	2.28%	1.58%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	97.69%	97.56%	92.67%	92.65%	98.42%
Debt to EBITDA	0.00	0.00	0.00	0.09	0.15	0.47	0.56	0.13
Net Debt to EBITDA	0.00	0.00	0.00	-1.90	-2.34	-1.25	-1.73	-2.09
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.09	0.15	0.11	0.17	0.13
Debt to NOPAT	0.00	0.00	0.00	0.13	0.27	0.81	1.04	0.24
Net Debt to NOPAT	0.00	0.00	0.00	-2.83	-4.08	-2.17	-3.20	-3.80
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.13	0.27	0.20	0.32	0.24
Altman Z-Score	11.40	10.41	7.54	7.49	5.55	5.17	4.56	4.94
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	2.86	3.11	3.47	3.53	2.86	2.69	2.64	2.89
Quick Ratio	2.51	2.72	3.09	3.20	2.50	2.42	2.45	2.54
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	12	61	55	204	-8.73	-10	19	6.77
Operating Cash Flow to CapEx	150.82%	1,861.19%	2,244.69%	5,340.87%	677.65%	-169.55%	823.05%	502.89%
Free Cash Flow to Firm to Interest Expense	9.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	5.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	1.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	3.09	2.93	2.60	2.34	2.10	2.26	2.21	2.15
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.08
Inventory Turnover	40.17	42.18	41.38	43.83	49.01	63.45	73.49	84.46
Fixed Asset Turnover	138.05	151.66	0.00	0.00	0.00	66.18	64.60	60.23
Accounts Payable Turnover	27.44	26.02	27.84	27.98	24.20	22.56	19.23	18.10
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	71.88
Days Inventory Outstanding (DIO)	9.09	8.65	8.82	8.33	7.45	5.75	4.97	4.32
Days Payable Outstanding (DPO)	13.30	14.03	13.11	13.04	15.08	16.18	18.98	20.17
Cash Conversion Cycle (CCC)	-4.21	-5.38	-4.29	-4.71	-7.64	-10.43	-14.02	56.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	317	338	342	227	279	330	345	372
Invested Capital Turnover	6.60	6.11	5.41	6.18	6.49	5.55	4.95	4.78
Increase / (Decrease) in Invested Capital	70	21	3.87	-115	51	51	15	27
Enterprise Value (EV)	3,179	2,447	1,476	1,660	1,080	801	655	724
Market Capitalization	3,262	2,550	1,594	1,913	1,254	889	766	851
Book Value per Share	$5.46	$5.97	$6.21	$6.46	$6.07	$5.65	$6.18	$6.82
Tangible Book Value per Share	$4.34	$4.92	$5.22	$5.53	$4.79	$4.41	$5.00	$5.66
Total Capital	400	441	460	492	464	451	493	508
Total Debt	0.00	0.00	0.00	11	11	33	36	8.03
Total Long-Term Debt	0.00	0.00	0.00	11	11	8.10	11	8.03
Net Debt	-83	-102	-118	-253	-174	-88	-111	-128
Capital Expenditures (CapEx)	5.06	4.30	4.17	4.07	5.48	4.82	5.29	6.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	260	242	249	146	170	223	232	228
Debt-free Net Working Capital (DFNWC)	343	345	367	410	355	345	380	364
Net Working Capital (NWC)	343	345	367	410	355	320	355	364
Net Nonoperating Expense (NNE)	-6.03	-1.73	-5.48	-9.15	-5.97	6.47	-3.68	-5.90
Net Nonoperating Obligations (NNO)	-83	-102	-118	-253	-174	-88	-111	-128
Total Depreciation and Amortization (D&A)	10	11	15	16	17	18	16	16
Debt-free, Cash-free Net Working Capital to Revenue	14.00%	12.10%	13.53%	8.28%	10.36%	13.20%	13.90%	13.31%
Debt-free Net Working Capital to Revenue	18.44%	17.21%	19.94%	23.30%	21.64%	20.39%	22.72%	21.22%
Net Working Capital to Revenue	18.44%	17.21%	19.94%	23.30%	21.64%	18.91%	21.23%	21.22%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.20	$1.13	$0.87	$1.32	$0.61	$0.47	$0.52	$0.54
Adjusted Weighted Average Basic Shares Outstanding	73.36M	74.00M	74.36M	74.70M	74.82M	74.34M	74.29M	73.75M
Adjusted Diluted Earnings per Share	$1.19	$1.12	$0.87	$1.32	$0.61	$0.47	$0.52	$0.53
Adjusted Weighted Average Diluted Shares Outstanding	74.35M	74.61M	74.59M	74.79M	74.96M	74.35M	74.34M	73.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	73.68M	74.04M	74.40M	74.72M	74.00M	74.39M	73.58M	73.49M
Normalized Net Operating Profit after Tax (NOPAT)	82	82	59	90	43	41	35	34
Normalized NOPAT Margin	4.42%	4.08%	3.21%	5.09%	2.59%	2.41%	2.08%	1.96%
Pre Tax Income Margin	7.14%	4.99%	4.62%	7.34%	3.99%	2.64%	3.17%	3.09%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	90.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	60.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	87.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	56.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	62.62%	68.48%	91.28%	61.52%	128.19%	185.07%	0.00%	0.00%
Augmented Payout Ratio	62.62%	68.82%	92.19%	62.20%	175.45%	188.20%	31.66%	15.32%

This table displays calculated financial ratios and metrics derived from Healthcare Services Group's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.27%	0.85%	-2.24%	-1.39%	-0.75%	-0.04%	1.49%	1.76%	4.07%	3.30%
EBITDA Growth	-62.25%	212.95%	-15.38%	-34.11%	-113.19%	52.76%	13.35%	-91.63%	2,635.48%	-45.45%
EBIT Growth	-85.06%	555.85%	-16.89%	-42.63%	-356.56%	65.92%	18.96%	-131.09%	459.76%	-51.60%
NOPAT Growth	-93.84%	495.10%	-16.37%	-47.61%	-653.84%	49.52%	18.27%	-128.83%	483.38%	-46.45%
Net Income Growth	-96.62%	229.61%	3.02%	21.03%	-1,667.39%	49.05%	31.17%	-121.66%	377.99%	-49.29%
EPS Growth	-100.00%	266.67%	6.67%	22.22%	0.00%	45.45%	31.25%	-118.18%	371.43%	-53.13%
Operating Cash Flow Growth	57.18%	-27.04%	46.03%	-17.91%	129.71%	115.98%	-59.81%	120.44%	46.67%	-26.78%
Free Cash Flow Firm Growth	-1,079.32%	23.93%	51.66%	42.08%	43.38%	114.03%	68.10%	93.06%	91.05%	-400.56%
Invested Capital Growth	24.51%	18.33%	13.71%	15.76%	10.11%	4.70%	6.33%	0.28%	4.17%	7.76%
Revenue Q/Q Growth	-2.44%	2.30%	-1.60%	0.41%	-1.80%	3.03%	-0.10%	0.67%	0.44%	2.26%
EBITDA Q/Q Growth	-69.91%	249.84%	-11.19%	-29.51%	-106.02%	4,152.04%	-35.32%	-94.80%	1,724.91%	-12.82%
EBIT Q/Q Growth	-88.95%	857.96%	-13.71%	-37.19%	-149.42%	719.52%	-39.45%	-116.42%	671.81%	-16.65%
NOPAT Q/Q Growth	-95.66%	2,285.87%	-22.82%	-34.37%	-145.83%	744.13%	-40.24%	-116.00%	709.35%	-10.04%
Net Income Q/Q Growth	-95.28%	4,798.14%	-26.00%	-29.28%	-161.15%	565.78%	-36.09%	-111.68%	884.68%	-15.04%
EPS Q/Q Growth	-100.00%	0.00%	-27.27%	-31.25%	-163.64%	557.14%	-34.38%	-109.52%	1,050.00%	-21.05%
Operating Cash Flow Q/Q Growth	-209.74%	331.34%	-171.16%	145.45%	-60.29%	1,581.80%	-152.65%	162.69%	-73.58%	739.61%
Free Cash Flow Firm Q/Q Growth	13.51%	44.25%	8.28%	-30.97%	15.46%	113.81%	-292.16%	71.53%	-9.05%	-364.02%
Invested Capital Q/Q Growth	4.23%	-3.66%	12.77%	2.23%	-0.85%	-8.40%	14.53%	-3.59%	2.99%	-5.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.07%	13.37%	13.15%	12.11%	8.37%	17.63%	15.24%	9.75%	14.81%	13.39%
EBITDA Margin	1.48%	5.06%	4.57%	3.21%	-0.20%	7.73%	5.10%	0.26%	4.79%	4.08%
Operating Margin	0.43%	4.05%	3.55%	2.22%	-1.12%	6.72%	4.16%	-0.68%	3.86%	3.15%
EBIT Margin	0.43%	4.05%	3.55%	2.22%	-1.12%	6.72%	4.16%	-0.68%	3.86%	3.15%
Profit (Net Income) Margin	0.08%	3.72%	2.80%	1.97%	-1.23%	5.55%	3.62%	-0.42%	3.28%	2.72%
Tax Burden Percent	32.43%	80.76%	72.24%	75.49%	79.69%	72.78%	71.83%	90.03%	74.60%	80.51%
Interest Burden Percent	55.44%	113.83%	109.13%	117.60%	137.82%	113.46%	121.03%	68.70%	113.77%	107.45%
Effective Tax Rate	67.57%	19.24%	27.76%	24.51%	0.00%	27.22%	28.17%	0.00%	25.40%	19.49%
Return on Invested Capital (ROIC)	0.77%	18.15%	12.32%	7.92%	-3.63%	24.20%	13.06%	-2.10%	12.73%	12.12%
ROIC Less NNEP Spread (ROIC-NNEP)	0.95%	16.69%	11.28%	6.54%	-1.10%	21.40%	9.45%	-2.39%	10.62%	11.43%
Return on Net Nonoperating Assets (RNNOA)	-0.30%	-5.03%	-2.39%	-1.32%	0.18%	-4.88%	-1.52%	0.42%	-1.83%	-2.85%
Return on Equity (ROE)	0.47%	13.12%	9.93%	6.59%	-3.45%	19.31%	11.53%	-1.68%	10.90%	9.26%
Cash Return on Invested Capital (CROIC)	-12.31%	-3.42%	-1.83%	-5.42%	-1.87%	5.69%	3.42%	6.87%	7.16%	1.89%
Operating Return on Assets (OROA)	0.96%	9.13%	8.14%	4.95%	-2.54%	14.85%	9.16%	-1.46%	8.44%	6.78%
Return on Assets (ROA)	0.17%	8.39%	6.42%	4.39%	-2.78%	12.27%	7.96%	-0.91%	7.17%	5.86%
Return on Common Equity (ROCE)	0.47%	13.12%	9.93%	6.59%	-3.45%	19.31%	11.53%	-1.68%	10.90%	9.26%
Return on Equity Simple (ROE_SIMPLE)	5.51%	0.00%	7.85%	7.99%	6.94%	0.00%	8.86%	6.78%	10.45%	0.00%
Net Operating Profit after Tax (NOPAT)	0.58	14	11	7.02	-3.22	21	13	-2.02	12	11
NOPAT Margin	0.14%	3.27%	2.56%	1.68%	-0.78%	4.89%	2.99%	-0.47%	2.88%	2.53%
Net Nonoperating Expense Percent (NNEP)	-0.18%	1.46%	1.04%	1.38%	-2.54%	2.80%	3.60%	0.29%	2.11%	0.69%
Return On Investment Capital (ROIC_SIMPLE)	-	3.07%	-	-	-	4.20%	-	-	-	2.18%
Cost of Revenue to Revenue	90.93%	86.63%	86.85%	87.89%	91.63%	82.37%	84.76%	90.25%	85.19%	86.61%
SG&A Expenses to Revenue	8.64%	9.32%	9.60%	9.89%	9.49%	10.91%	11.08%	10.42%	10.95%	10.24%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.64%	9.32%	9.60%	9.89%	9.49%	10.91%	11.08%	10.42%	10.95%	10.24%
Earnings before Interest and Taxes (EBIT)	1.79	17	15	9.30	-4.60	28	18	-2.89	17	14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6.13	21	19	13	-0.81	33	22	1.12	21	18
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.09	2.13	2.34	2.46	1.75	1.68	1.94	1.65	1.68	1.70
Price to Tangible Book Value (P/TBV)	2.68	2.72	2.95	3.06	2.19	2.08	2.38	2.02	2.03	2.05
Price to Revenue (P/Rev)	0.52	0.53	0.61	0.66	0.46	0.46	0.55	0.46	0.48	0.50
Price to Earnings (P/E)	45.43	33.22	36.44	38.34	32.02	19.14	21.88	23.98	14.82	21.83
Dividend Yield	7.12%	7.11%	6.15%	5.71%	8.17%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.20%	3.01%	2.74%	2.61%	3.12%	5.23%	4.57%	4.17%	6.75%	4.58%
Enterprise Value to Invested Capital (EV/IC)	2.34	2.43	2.59	2.73	1.88	1.90	2.13	1.81	1.84	1.94
Enterprise Value to Revenue (EV/Rev)	0.48	0.47	0.57	0.62	0.42	0.39	0.50	0.41	0.43	0.42
Enterprise Value to EBITDA (EV/EBITDA)	14.34	11.36	14.37	17.27	13.35	10.15	12.58	12.60	9.52	11.84
Enterprise Value to EBIT (EV/EBIT)	20.87	15.12	19.28	24.10	19.34	13.64	16.59	17.86	12.12	16.07
Enterprise Value to NOPAT (EV/NOPAT)	27.28	19.67	25.05	31.85	25.42	18.86	22.99	25.29	16.72	21.55
Enterprise Value to Operating Cash Flow (EV/OCF)	2,529.34	0.00	168.25	252.42	41.85	15.05	24.96	16.15	16.43	23.49
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	34.06	64.29	26.33	26.25	106.81
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.08	0.08	0.10	0.11	0.13	0.08	0.11	0.09	0.07	0.02
Long-Term Debt to Equity	0.02	0.02	0.02	0.03	0.03	0.02	0.02	0.02	0.02	0.02
Financial Leverage	-0.32	-0.30	-0.21	-0.20	-0.17	-0.23	-0.16	-0.17	-0.17	-0.25
Leverage Ratio	1.68	1.72	1.65	1.69	1.71	1.73	1.66	1.69	1.67	1.67
Compound Leverage Factor	0.93	1.96	1.80	1.99	2.35	1.96	2.01	1.16	1.90	1.79
Debt to Total Capital	7.40%	7.33%	9.00%	10.27%	11.37%	7.35%	9.63%	7.94%	6.51%	1.58%
Short-Term Debt to Total Capital	5.48%	5.54%	7.23%	7.97%	9.03%	5.07%	7.62%	5.86%	4.78%	0.00%
Long-Term Debt to Total Capital	1.92%	1.79%	1.77%	2.30%	2.34%	2.28%	2.02%	2.08%	1.73%	1.58%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	92.60%	92.67%	91.00%	89.73%	88.63%	92.65%	90.37%	92.06%	93.49%	98.42%
Debt to EBITDA	0.60	0.47	0.65	0.86	1.07	0.56	0.76	0.74	0.45	0.13
Net Debt to EBITDA	-1.42	-1.25	-1.02	-1.17	-1.22	-1.73	-1.18	-1.65	-1.26	-2.09
Long-Term Debt to EBITDA	0.16	0.11	0.13	0.19	0.22	0.17	0.16	0.19	0.12	0.13
Debt to NOPAT	1.15	0.81	1.13	1.58	2.03	1.04	1.38	1.49	0.79	0.24
Net Debt to NOPAT	-2.71	-2.17	-1.78	-2.16	-2.32	-3.20	-2.16	-3.30	-2.22	-3.80
Long-Term Debt to NOPAT	0.30	0.20	0.22	0.35	0.42	0.32	0.29	0.39	0.21	0.24
Altman Z-Score	4.96	5.00	5.53	5.26	4.58	4.47	4.74	4.41	4.67	4.82
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.82	2.69	3.15	2.90	2.84	2.64	2.77	2.74	2.93	2.89
Quick Ratio	2.53	2.42	2.85	2.65	2.60	2.45	2.45	2.41	2.59	2.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-67	-37	-34	-45	-38	5.23	-11	-3.10	-3.38	-16
Operating Cash Flow to CapEx	-627.92%	2,655.80%	-1,709.34%	699.06%	159.78%	3,450.45%	-1,198.02%	1,374.81%	317.99%	2,569.48%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.23	2.26	2.29	2.23	2.27	2.21	2.20	2.16	2.19	2.15
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.08
Inventory Turnover	60.82	63.45	65.97	67.79	70.40	73.49	75.94	77.69	80.45	84.46
Fixed Asset Turnover	0.00	66.18	67.09	63.72	62.62	64.60	63.80	59.36	59.11	60.23
Accounts Payable Turnover	25.48	22.56	23.15	22.33	21.37	19.23	21.17	21.32	19.80	18.10
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	71.88
Days Inventory Outstanding (DIO)	6.00	5.75	5.53	5.38	5.18	4.97	4.81	4.70	4.54	4.32
Days Payable Outstanding (DPO)	14.32	16.18	15.77	16.35	17.08	18.98	17.24	17.12	18.43	20.17
Cash Conversion Cycle (CCC)	-8.32	-10.43	-10.24	-10.96	-11.90	-14.02	-12.43	-12.42	-13.90	56.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	342	330	372	380	377	345	396	381	393	372
Invested Capital Turnover	5.46	5.55	4.81	4.73	4.65	4.95	4.37	4.42	4.42	4.78
Increase / (Decrease) in Invested Capital	67	51	45	52	35	15	24	1.08	16	27
Enterprise Value (EV)	802	801	963	1,037	709	655	843	689	724	724
Market Capitalization	881	889	1,032	1,108	774	766	922	779	820	851
Book Value per Share	$5.70	$5.65	$5.92	$6.07	$5.95	$6.18	$6.42	$6.40	$6.66	$6.82
Tangible Book Value per Share	$4.45	$4.41	$4.71	$4.87	$4.76	$5.00	$5.24	$5.23	$5.49	$5.66
Total Capital	456	451	484	502	498	493	525	512	523	508
Total Debt	34	33	44	52	57	36	51	41	34	8.03
Total Long-Term Debt	8.75	8.10	8.59	12	12	11	11	11	9.03	8.03
Net Debt	-80	-88	-69	-70	-65	-111	-79	-90	-96	-128
Capital Expenditures (CapEx)	1.58	0.86	0.95	1.06	1.84	1.43	2.17	1.19	1.36	1.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)	242	223	271	278	269	232	281	263	276	228
Debt-free Net Working Capital (DFNWC)	356	345	383	399	391	380	411	394	406	364
Net Working Capital (NWC)	331	320	348	359	346	355	371	364	381	364
Net Nonoperating Expense (NNE)	0.26	-1.92	-0.98	-1.24	1.83	-2.79	-2.66	-0.24	-1.70	-0.83
Net Nonoperating Obligations (NNO)	-80	-88	-69	-70	-65	-111	-79	-90	-96	-128
Total Depreciation and Amortization (D&A)	4.34	4.30	4.25	4.14	3.79	4.31	3.99	4.02	3.98	4.10
Debt-free, Cash-free Net Working Capital to Revenue	14.38%	13.20%	16.11%	16.57%	16.11%	13.90%	16.78%	15.61%	16.21%	13.31%
Debt-free Net Working Capital to Revenue	21.10%	20.39%	22.79%	23.85%	23.37%	22.72%	24.50%	23.37%	23.85%	21.22%
Net Working Capital to Revenue	19.62%	18.91%	20.70%	21.46%	20.67%	21.23%	22.12%	21.59%	22.38%	21.22%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.22	$0.17	$0.12	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.16
Adjusted Weighted Average Basic Shares Outstanding	74.34M	74.34M	74.50M	74.48M	74.36M	74.29M	73.93M	73.85M	73.69M	73.75M
Adjusted Diluted Earnings per Share	$0.00	$0.22	$0.17	$0.12	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.15
Adjusted Weighted Average Diluted Shares Outstanding	74.35M	74.35M	74.52M	74.57M	74.36M	74.34M	74.06M	73.85M	73.93M	73.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	74.09M	74.39M	74.20M	74.20M	73.85M	73.58M	73.65M	73.38M	73.29M	73.49M
Normalized Net Operating Profit after Tax (NOPAT)	1.25	14	11	7.02	-3.22	21	13	-2.02	12	11
Normalized NOPAT Margin	0.30%	3.27%	2.56%	1.68%	-0.78%	4.89%	2.99%	-0.47%	2.88%	2.53%
Pre Tax Income Margin	0.24%	4.61%	3.87%	2.61%	-1.54%	7.62%	5.03%	-0.47%	4.39%	3.38%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	270.65%	185.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	344.69%	188.20%	8.95%	8.59%	23.19%	31.66%	24.01%	40.93%	19.75%	15.32%

Frequently Asked Questions About Healthcare Services Group's Financials

When does Healthcare Services Group's fiscal year end?

According to the most recent income statement we have on file, Healthcare Services Group's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Healthcare Services Group's net income changed over the last 7 years?

Healthcare Services Group's net income appears to be on a downward trend, with a most recent value of $39.47 million in 2024, falling from $88.23 million in 2017. The previous period was $38.39 million in 2023.

What is Healthcare Services Group's operating income?

Healthcare Services Group's total operating income in 2024 was $45.03 million, based on the following breakdown:

Total Gross Profit: $228.09 million
Total Operating Expenses: $183.06 million

How has Healthcare Services Group revenue changed over the last 7 years?

Over the last 7 years, Healthcare Services Group's total revenue changed from $1.86 billion in 2017 to $1.72 billion in 2024, a change of -7.8%.

How much debt does Healthcare Services Group have?

Healthcare Services Group's total liabilities were at $302.85 million at the end of 2024, a 9.3% decrease from 2023, and a 9.7% increase since 2017.

How much cash does Healthcare Services Group have?

In the past 7 years, Healthcare Services Group's cash and equivalents has ranged from $9.56 million in 2017 to $139.33 million in 2020, and is currently $56.78 million as of their latest financial filing in 2024.

How has Healthcare Services Group's book value per share changed over the last 7 years?

Over the last 7 years, Healthcare Services Group's book value per share changed from 5.46 in 2017 to 6.82 in 2024, a change of 25.0%.

Remove Ads

Related Companies

This page (NASDAQ:HCSG) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healthcare Services Group (HCSG) Financials

Frequently Asked Questions About Healthcare Services Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Healthcare Services Group (HCSG) Financials

Annual Income Statements for Healthcare Services Group

Quarterly Income Statements for Healthcare Services Group

Annual Cash Flow Statements for Healthcare Services Group

Quarterly Cash Flow Statements for Healthcare Services Group

Annual Balance Sheets for Healthcare Services Group

Quarterly Balance Sheets for Healthcare Services Group

Annual Metrics and Ratios for Healthcare Services Group

Quarterly Metrics and Ratios for Healthcare Services Group

Frequently Asked Questions About Healthcare Services Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools